FILED AND SPONSOR-REPORTED ETF HOLDINGS
PRME Included in ETFs
Dates are first observed in retained official snapshots; “baseline” means the security was already present in the earliest retained snapshot and is not an invented original addition date.
Current ETFs holding PRME
7 latest ETF portfolios currently report this security.
| ETF | Fund | Weight | Added / first observed | Latest report |
|---|---|---|---|---|
| ARKG | ARK Genomic Revolution ETF | 1.412944% | 2026-01-30 (baseline) | 2026-04-30 |
| NXTE | AXS Green Alpha ETF | 1.135491% | 2025-12-31 (baseline) | 2026-03-31 |
| BBC | Virtus Biotech Clinical Trials Etf | 0.63921% | 2026-01-30 (baseline) | 2026-04-30 |
| LABU | Direxion Daily S&P Biotech Bull 3X Shares | 0.158523% | 2026-04-30 (baseline) | 2026-04-30 |
| GINN | Goldman Sachs Innovate Equity ETF | 0.058492% | 2025-11-30 (baseline) | 2026-02-28 |
| ISCB | iShares Morningstar Small-Cap ETF | 0.004457% | 2026-01-31 (baseline) | 2026-04-30 |
| IWV | iShares Russell 3000 ETF | 0.000214% | 2025-12-31 (baseline) | 2026-03-31 |
Previous ETFs holding PRME
| ETF | Fund | Added / first observed | Removed / first absent |
|---|---|---|---|
| EHLS | Even Herd Long Short ETF | 2025-12-31 (baseline) | 2026-03-31 |